"West Michigan Rheumatology has been providing compassionate, high quality care to patients suffering from a variety of rheumatological conditions throughout West Michigan for over 25 years."

During the past decade, West Michigan Rheumatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Michigan Rheumatology" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cytori Therapeutics" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Michigan Rheumatology" #1 collaborator was "Childhood Arthritis and Rheumatology Research Alliance" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "West Michigan Rheumatology" are "Rheumatoid Arthritis" (3 trials), "Raynaud's Disease" (2 trials), "Scleroderma" (2 trials), "Systemic Sclerosis" (2 trials) and "Acute Gout" (1 trials). Many other conditions were trialed in "West Michigan Rheumatology" in a lesser frequency.

Most popular intervention types in "West Michigan Rheumatology" are "Drug" (10 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (3 trials), "Placebo" (3 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "BI 695500" (1 trials). Other intervention names were less common.

The vast majority of trials in "West Michigan Rheumatology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "West Michigan Rheumatology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in West Michigan Rheumatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in West Michigan Rheumatology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".